Evidence map›Paper›PMID 31245190›Full record

ArticleCureus2019

Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient.

Tariq Kewan, Mohammad Alomari, Shrouq Khazaaleh, Fahrettin Covut, May Olayan

Registry-linked trialOpen access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05576545 (Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05576545 nacompletednot on this mapstarted 2020, after this paper: background citation

Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment

TypeinterventionalSponsorKaohsiung Medical University Chung-Ho Memorial HospitalRan2020 to 2022Enrolled73ConditionsBreast Cancer, Breast Neoplasm, Breast Malignant Tumor, ResilienceArmsThe Breast Cancer Self-Care App
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tariq KewanInternal Medicine, Cleveland Clinic - Fairview Hospital, Cleveland, USA.
Mohammad AlomariInternal Medicine, Cleveland Clinic Foundation, Cleveland, USA.
Shrouq KhazaalehInternal Medicine, Cleveland Clinic Foundation, Cleveland, USA.
Fahrettin CovutInternal Medicine, Cleveland Clinic - Fairview Hospital, Cleveland, USA.
May OlayanInternal Medicine, Cleveland Clinic - Fairview Hospital, Cleveland, USA.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Docetaxel-induced hand-foot syndrome (HFS) at low doses is a very rare side effect that usually occurs in a dose-dependent manner. HFS can be managed with conservative measures and may need chemotherapy discontinuation. In this report we present a case of HFS in a breast cancer patient after one dose of docetaxel.

Indexed as

docetaxelhand-foot syndrome

Identifiers

PMID31245190
PMCPMC6559678
OpenAlexW2931792975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.